A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy

Keith G. Rasmussen, Simon Kung, Maria Isabel Lapid, Tyler S. Oesterle, Jennifer R. Geske, Gregory A. Nuttall, William C. Oliver, John P. Abenstein

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

To assess the clinical utility of ketamine as an anesthetic agent for electroconvulsive therapy (ECT), based upon recent findings that ketamine may have antidepressant properties. Depressed ECT patients were randomly assigned to receive anesthesia with either ketamine or methohexital. Outcome measures included assessments of depressive severity, cognition, post-anesthesia side effects, and hemodynamics. Twenty one patients were treated with ketamine and 17 with methohexital. There were no significant differences in depression or cognitive outcomes between the two drugs. Additionally, there were no measures of post-anesthesia tolerability or hemodynamics which favored ketamine. Ketamine anesthesia does not accelerate the antidepressant effect of ECT or diminish the cognitive side effects, at least as measured in this study. Furthermore, there is no apparent benefit of ketamine for speed or quality of post-ECT recovery, and it is associated with higher systolic blood pressures after the treatments. Ketamine is associated with longer motor seizure duration than methohexital.

Original languageEnglish (US)
Pages (from-to)362-365
Number of pages4
JournalPsychiatry Research
Volume215
Issue number2
DOIs
StatePublished - Feb 28 2014

Fingerprint

Methohexital
Electroconvulsive Therapy
Ketamine
Anesthesia
Antidepressive Agents
Hemodynamics
Cognition
Anesthetics
Seizures
Outcome Assessment (Health Care)
Depression
Blood Pressure
Hypertension

Keywords

  • Anesthesia
  • Cognition
  • Hemodynamics
  • Major depression
  • Mood disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Medicine(all)

Cite this

Rasmussen, K. G., Kung, S., Lapid, M. I., Oesterle, T. S., Geske, J. R., Nuttall, G. A., ... Abenstein, J. P. (2014). A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy. Psychiatry Research, 215(2), 362-365. https://doi.org/10.1016/j.psychres.2013.12.027

A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy. / Rasmussen, Keith G.; Kung, Simon; Lapid, Maria Isabel; Oesterle, Tyler S.; Geske, Jennifer R.; Nuttall, Gregory A.; Oliver, William C.; Abenstein, John P.

In: Psychiatry Research, Vol. 215, No. 2, 28.02.2014, p. 362-365.

Research output: Contribution to journalArticle

Rasmussen, KG, Kung, S, Lapid, MI, Oesterle, TS, Geske, JR, Nuttall, GA, Oliver, WC & Abenstein, JP 2014, 'A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy', Psychiatry Research, vol. 215, no. 2, pp. 362-365. https://doi.org/10.1016/j.psychres.2013.12.027
Rasmussen, Keith G. ; Kung, Simon ; Lapid, Maria Isabel ; Oesterle, Tyler S. ; Geske, Jennifer R. ; Nuttall, Gregory A. ; Oliver, William C. ; Abenstein, John P. / A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy. In: Psychiatry Research. 2014 ; Vol. 215, No. 2. pp. 362-365.
@article{7d35e4ab5a234960853caa5d47acc932,
title = "A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy",
abstract = "To assess the clinical utility of ketamine as an anesthetic agent for electroconvulsive therapy (ECT), based upon recent findings that ketamine may have antidepressant properties. Depressed ECT patients were randomly assigned to receive anesthesia with either ketamine or methohexital. Outcome measures included assessments of depressive severity, cognition, post-anesthesia side effects, and hemodynamics. Twenty one patients were treated with ketamine and 17 with methohexital. There were no significant differences in depression or cognitive outcomes between the two drugs. Additionally, there were no measures of post-anesthesia tolerability or hemodynamics which favored ketamine. Ketamine anesthesia does not accelerate the antidepressant effect of ECT or diminish the cognitive side effects, at least as measured in this study. Furthermore, there is no apparent benefit of ketamine for speed or quality of post-ECT recovery, and it is associated with higher systolic blood pressures after the treatments. Ketamine is associated with longer motor seizure duration than methohexital.",
keywords = "Anesthesia, Cognition, Hemodynamics, Major depression, Mood disorder",
author = "Rasmussen, {Keith G.} and Simon Kung and Lapid, {Maria Isabel} and Oesterle, {Tyler S.} and Geske, {Jennifer R.} and Nuttall, {Gregory A.} and Oliver, {William C.} and Abenstein, {John P.}",
year = "2014",
month = "2",
day = "28",
doi = "10.1016/j.psychres.2013.12.027",
language = "English (US)",
volume = "215",
pages = "362--365",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy

AU - Rasmussen, Keith G.

AU - Kung, Simon

AU - Lapid, Maria Isabel

AU - Oesterle, Tyler S.

AU - Geske, Jennifer R.

AU - Nuttall, Gregory A.

AU - Oliver, William C.

AU - Abenstein, John P.

PY - 2014/2/28

Y1 - 2014/2/28

N2 - To assess the clinical utility of ketamine as an anesthetic agent for electroconvulsive therapy (ECT), based upon recent findings that ketamine may have antidepressant properties. Depressed ECT patients were randomly assigned to receive anesthesia with either ketamine or methohexital. Outcome measures included assessments of depressive severity, cognition, post-anesthesia side effects, and hemodynamics. Twenty one patients were treated with ketamine and 17 with methohexital. There were no significant differences in depression or cognitive outcomes between the two drugs. Additionally, there were no measures of post-anesthesia tolerability or hemodynamics which favored ketamine. Ketamine anesthesia does not accelerate the antidepressant effect of ECT or diminish the cognitive side effects, at least as measured in this study. Furthermore, there is no apparent benefit of ketamine for speed or quality of post-ECT recovery, and it is associated with higher systolic blood pressures after the treatments. Ketamine is associated with longer motor seizure duration than methohexital.

AB - To assess the clinical utility of ketamine as an anesthetic agent for electroconvulsive therapy (ECT), based upon recent findings that ketamine may have antidepressant properties. Depressed ECT patients were randomly assigned to receive anesthesia with either ketamine or methohexital. Outcome measures included assessments of depressive severity, cognition, post-anesthesia side effects, and hemodynamics. Twenty one patients were treated with ketamine and 17 with methohexital. There were no significant differences in depression or cognitive outcomes between the two drugs. Additionally, there were no measures of post-anesthesia tolerability or hemodynamics which favored ketamine. Ketamine anesthesia does not accelerate the antidepressant effect of ECT or diminish the cognitive side effects, at least as measured in this study. Furthermore, there is no apparent benefit of ketamine for speed or quality of post-ECT recovery, and it is associated with higher systolic blood pressures after the treatments. Ketamine is associated with longer motor seizure duration than methohexital.

KW - Anesthesia

KW - Cognition

KW - Hemodynamics

KW - Major depression

KW - Mood disorder

UR - http://www.scopus.com/inward/record.url?scp=84893804817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893804817&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2013.12.027

DO - 10.1016/j.psychres.2013.12.027

M3 - Article

C2 - 24388729

AN - SCOPUS:84893804817

VL - 215

SP - 362

EP - 365

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 2

ER -